Repaglinide
NDC 62135-948, Repaglinide, tablet, from Chartwell RX, LLC.
- Product NDC
- 62135-948
- Status
- Listed
- Labeler
- Chartwell RX, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078555
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62135-948 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- REPAGLINIDE2 mg/1
Pharmacologic classes
Glinide [EPC]; Potassium Channel Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62135-948-90 | 62135094890 | 90 TABLET in 1 BOTTLE (62135-948-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/cb995e92-295e-4638-a064-978211f5afe1NADAC price for package 62135094890
GET /v1/drugs/nadac/62135094890
Use it
Look up 62135-948 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62135-948 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62135-948. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.